Background: BPD is a chronic lung disease affecting preterm infants leading to increased morbidity and mortality. Main risk factors include premature birth, mechanical ventilation (MV), hyperoxia and inflammation. A newborn rat ventilation model with reversible intubation was used to study delayed gene expression modifications to increase our understanding of its pathophysiology.
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Methods: LPS was injected intraperitoneally (2mg/kg) to male rat pups on postnatal day 4 or 5 to mimic systemic inflammation. Twenty-four hours after injection they were intubated and ventilated for 6h with tidal volume of 15ml/kg and 21% or 60%O 2 . After weaning from anesthesia, they were returned to their mothers for 48h. Gene expression was measured by Affymetrix®Gene-Arrays in four groups (n=9/Group) and verified by qPCR.
Results: Expression changes were mainly found in genes involved in inflammation and extracellular matrix remodeling. Among them MMP-9 and several of its regulator genes were significantly modified. Conclusion: MMP-9 is known to be important in lung development, angiogenesis and tissue repair. In our BPD-model, MMP-9 pathway seemed to be a central target. Several genes increasing MMP-9 activity were synergistically upregulated, highlighting its potential role in lung injury and repair. Therefore, the role of MMP-9 in the pathophysiology of BPD deserves further investigation.
